ArticleGenome biology2026
Parameter-efficient fine-tuning enables scalable transfer of regulatory sequence models to novel contexts.
Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Teaching an old dog new cells.Nature methods · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDNA sequence deep learning models can accurately predict epigenetic and transcriptional profiles, enabling analysis of gene regulation and genetic variant effects. While large-scale models like Enformer and Borzoi are trained on abundant data, they cannot cover all cell states and assays, necessitating training new model to analyze gene regulation in novel contexts. However, training models from scratch for new datasets is computationally expensive.
resultsIn this study, we systematically develop and evaluate a transfer learning framework based on parameter-efficient fine-tuning for supervised regulatory sequence models. Using the state-of-the-art model Borzoi, our framework enables accurate model transfer while significantly reducing runtime and memory requirements. Across bulk and single cell RNA-seq datasets, the transferred models effectively predict held-out gene expression changes, identify regulatory drivers in perturbation conditions, and predict cell-type-specific variant effects. We further demonstrate that transferring Borzoi to relevant cell types facilitates mechanistic interpretation of fine-mapped GWAS variants.
conclusionsOur framework offers a scalable and practical solution for extending large sequence models to novel biological contexts, enabling mechanistic insight into gene regulation and variant effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.